Livero, Jan-Mar (1Q) Ordinary Profit Decreases by 10%

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

Thu May 15, 2025 12:00 pm JST Earnings

9245 Livero Inc. 【J-GAAP】

Earnings Report

Livero Inc. <9245> [TSE Growth] announced its financial results at noon (12:00) on May 15th. The consolidated ordinary profit for the first quarter of the fiscal year ending December 2025 (January to March) decreased 10.5% from the same period last year to 282 million yen. The progress rate toward the full-year plan of 800 million yen was 35.3%, below the three-year average of 89.1%.

In the most recent three-month period, from January to March (1Q), the operating profit margin decreased from 28.1% in the same period last year to 22.6%.

Kabutan News

Actual Results

Accumulated Results 1st Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Jan - Mar, 2023	830	85	85	52	9.9	32.7	May 15, 2023	J-GAAP
Jan - Mar, 2024	1,111	312	315	206	39.6	54.2	May 15, 2024	J-GAAP
Jan - Mar, 2025	1,246	281	282	183	35.0	ー	May 15, 2025	J-GAAP
YoY	+12.2%	-9.9%	-10.5%	-11.2%	-11.6%

Current Period Guidance

H1 Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Jan - Jun, 2024	2,130	578	581	394	75.5	0	Aug 9, 2024	J-GAAP
Jan - Jun, 2025 Guidance	ー	ー	ー	ー	－	0	Feb 14, 2025	J-GAAP
YoY	－	－	－	－	－

Current Period Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Dec, 2023	2,900	178	179	103	19.9	0	Feb 14, 2024	J-GAAP
Dec, 2024	3,586	455	474	338	64.8	30	Feb 14, 2025	J-GAAP
Dec, 2025 Guidance	4,670	800	800	530	100.7	30	Feb 14, 2025	J-GAAP
YoY	+30.2%	+75.8%	+68.8%	+56.8%	+55.5%

Quarterly Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Jan - Mar, 2024	1,111	312	315	206	39.6	28.1	May 15, 2024	J-GAAP
Apr - Jun, 2024	1,019	266	266	188	36.0	26.1	Aug 9, 2024	J-GAAP
Jul - Sep, 2024	697	-7	-6	-3	-0.6	-1.0	Nov 14, 2024	J-GAAP
Oct - Dec, 2024	759	-116	-101	-53	-10.2	-15.3	Feb 14, 2025	J-GAAP
Jan - Mar, 2025	1,246	281	282	183	35.0	22.6	May 15, 2025	J-GAAP
YoY	+12.2%	-9.9%	-10.5%	-11.2%	-11.6%